A Study of JZP150 in Adults With Posttraumatic Stress Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a 12-week, double-blind, placebo-controlled, randomized, parallel-group, multicenter study of the safety and efficacy of JZP150 in the treatment of adult participants with post-traumatic stress disorder (PTSD).
Epistemonikos ID: e0eb96c1b805d4743677d231124e3d7b8b899e39
First added on: May 09, 2024